MIRA INFORM REPORT

 

 

Report Date :

24.02.2011

 

IDENTIFICATION DETAILS

 

Name :

F.H.C.-FARMACEUTICA LDA

 

 

Registered Office :

Parque Industrial Manuel Lourenço Ferreira, Lote 2 - Apartado 45, Mortagua

 

 

Country :

Portugal

 

 

Financials (as on) :

31.12.2009

 

 

Date of Incorporation :

09.02.1998

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Wholesale trade of pharmaceutical products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

Portugal

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Identification

 

 

Name

F.H.C.-FARMACEUTICA LDA

 

 

 

 

V.A.T. Number / NIF

504061500

Address

Parque Industrial Manuel Lourenço Ferreira, Lote 2 - Apartado 45

 

 

Locality

MORTAGUA

Postal Code

3450-232-MORTAGUA

Municipality

MORTAGUA

District

VISEU

Telephone

231927510, 231927524

 

 

Fax

231927520

 

 

E-Mail

infor@fhc.pt 

 

 

Web Site

www.fhc.pt

 

 

 

 

 

 

C.A.E.(Rev 3)

46460- Wholesale trade of pharmaceutical products

 

 

 

 

All the amounts are express in Euros, otherwise you will be advised

 

 

 

Summary

 

 

Legal Form

Private Limited Company

 

 

Constitution

09-02-1998

V.A.T. Number / NIF

504061500

Employees

200

Capital

250.000,00

Sales in : 31-12-2009

50.245.514,00

Shareholders Funds in: 31-12-2009

16.046.770,00

Credit

Recommended

Credit Limit

62.350,00

Condition

Normal

Tendency

Stationary

Financing

Guaranteed

Payments

Good

Actual Condition

In activity

 

 

 

 

Management Bodies

 

 

JOAQUIM ANTONIO DE MATOS CHAVES

Managing-Partner

 

 

Banks and Financial Institutions

 

 

BANCO ESPIRITO SANTO, SA

Tondela

MILLENNIUM BCP

Mortágua

 


Historical

 

 

Registed on the Register Record Office of Mortagua with the Register Number 504061500 previous number 192 in 09-02-1998

Constitution celebrated in 09-02-1998 published on Diário da República number 59 of 11-03-1998

To oblige the company it is necessary 2 signature

 

 

Changes to Society

 

In 11-07-2003 on Diário da República number 234 of 09-10-2003 increase of capital to 250.000 €

In 09-02-1999 on Diário da República number 86 of 13-04-1999 board of director's change

 

 

 

Capital

 

 

The Capital is 250.000,00

 

 

with the following distribution

 

JOAQUIM ANTONIO DE MATOS CHAVES

125.000,00

50%

LUIS PEDRO GONCALVES SIMOES

125.000,00

50%

 

 

Biographies

 

 

Name

JOAQUIM ANTONIO DE MATOS CHAVES

Function

Managing-Partner

Address

Rua Dr. Teófilo da Cruz - Edifício Magistral, 3ºC

Locality

TONDELA

Civil State

Married

Consort

Isabel Cristina Jesus Neves Ferreira

Professional Connections

The subject has connections with the following company (ies)

 

NOVAMED-EQUIPAMENTOS MEDICOS SA as Board of Director's President .

 

OVERPHARMA-PRODUTOS MEDICOS E FARMACEUTICOS LDA as Managing-Partner with a participation of 79.166,77 , in a capital of 250.000,00 .

 

CRISTRAVEL-VIAGENS E TURISMO LDA as Manager .

 

PHAGECON-SERVICOS E CONSULTORIA FARMACEUTICA LDA as Managing-Partner with a participation of 16.000,00 , in a capital of 60.000,00 .

 

ALEXANDRA PINTO PACHECO UNIPESSOAL LDA as Manager .

 

HEALTHICS-SGPS SA as Administrator .

 

EMPIFARMA-PRODUTOS FARMACEUTICOS SA as Administrator .

 

VITALGEST-CLINICAS DENTARIAS LDA as Managing-Partner with a participation of 37.500,00 , in a capital of 75.000,00 .

 

ACTRADIA-FARMACEUTICA LDA as Managing-Partner with a participation of 2.500,00 , in a capital of 5.000,00 .

 

ZEONE-INFORMATICA LDA as Managing-Partner with a participation of 3.334,00 , in a capital of 10.002,00 .

 

LABORATORIOS BASI-INDUSTRIA FARMACEUTICA SA as Board of Director's President .

 

Name

Eng. LUIS PEDRO GONCALVES SIMOES

Function

Partner

Address

Urbanização Quinta de S. Jerónimo-Lote 21-D, 1ºDto.

Locality

COIMBRA

Birth Date

29-03-1972

Naturality

Coimbra

Civil State

Divorced

Academical Degree

Licênciado em engenharia electrotécnica

Professional Connections

The subject has connections with the following company (ies)

 

VITALGEST-CLINICAS DENTARIAS LDA as Managing-Partner with a participation of 37.500,00 , in a capital of 75.000,00 .

 

NOVAMED-EQUIPAMENTOS MEDICOS SA as Administrator .

 

ALEXANDRA PINTO PACHECO UNIPESSOAL LDA as Manager .

 

HEALTHICS-SGPS SA as Administrator .

 

EMPIFARMA-PRODUTOS FARMACEUTICOS SA as Administrator .

 

OVERPHARMA-PRODUTOS MEDICOS E FARMACEUTICOS LDA as Manager .

 

ACTRADIA-FARMACEUTICA LDA as Managing-Partner with a participation of 2.500,00 , in a capital of 5.000,00 .

 

ZEONE-INFORMATICA LDA as Managing-Partner with a participation of 3.334,00 , in a capital of 10.002,00 .

 

PHAGECON-SERVICOS E CONSULTORIA FARMACEUTICA LDA as Managing-Partner with a participation of 16.000,00 , in a capital of 60.000,00 .

 

LABORATORIOS BASI-INDUSTRIA FARMACEUTICA SA as Administrator .

Observations

It also has an address in: Rua Miguel Torga, 249 – 5. º A, Coimbra.

 

 

Special Information

 

 

Event

General Description

Quality Certification

The bearer is certified by the standard ISO 9001/2000.

 

 

Activities

 

 

Line of Business

Percentage

Import, export, marketing and distribution of pharmaceuticals, medical devices, furniture and hospital equipment and diagnostic material

100%

 

 

Type of Clients

Hospitals/Pharmacies

 

 

Sales Conditions

Cash/credit

 

 

Exports to

ANGOLA, FRANCE, CAPE VERDE, GUINEA-BISSAU, MOZAMBIQUE, SAO TOME AND PRINCIPE, IVORY COAST, SPAIN, AZERBAIJAN, LEBANON, MACEDONIA, NETHERLANDS

 

 

 

 

Employees

 

 

Total

200

 

 

Head Office and Installations

 

 

Head office and warehouse Parque Indústrial Manuel Lourenço Ferreira, Lt 2 - Apartado 45, MORTAGUA, 3450-232, MORTAGUA, Tel:231927510, Fax:231927520

 

 

 

Incidents

 

 

There are no of incidents on our database

 

 

Business Concept

 

 

Consulted sources say that the subject has been respecting its payments and commercial commitments, so credit connections with this company are recommended.

 

 

Participations

 

 

The subject participates on the following company(ies)

 

NAME

LABORATORIOS BASI-INDUSTRIA FARMACEUTICA SA

Address

Rua Padrão, 98

Locality

COIMBRA

Telephone

239827021

Fax

239492845

E-Mail

basi@basi.pt

Web Site

www.basi.pt

C.A.E.

21201- Manufacture of medicines

Capital

1.326.935,00

Participation

98%

 

 

Financial Elements

 

 

 

31-12-2009

 

Intangible Assets

541.693,00

 

Tangible Assets

1.373.003,00

 

Investments

5.112.571,00

 

Stocks

9.592.537,00

 

Short Term Receivable

15.078.855,00

 

Banks and Cash

3.145.566,00

 

Accruals and Deferrals

51.377,00

 

Total Assets

34.895.602,00

 

Shareholder's Funds

16.046.770,00

 

Medium and Long Term Payable

2.847.125,00

 

Short Term Payable

15.904.271,00

 

Accruals and Deferrals

97.436,00

 

Total Liabilities and Shareholder's Funds

34.895.602,00

 

Cost of Goods and Consumable Materials

40.423.145,00

 

Outside Supplies and Services

4.847.512,00

 

Personnel Costs

1.258.608,00

 

Sales

50.245.514,00

 

Supplementary Income

8.903,00

 

 

 

Comparatives

 

 

 

31-12-2007

31-12-2008

31-12-2009

Net Sales

34.012.945,00

42.337.147,00

50.245.514,00

Net Income For the Year

2.446.273,00

2.943.163,00

3.677.264,00

Current Assets

28.292.296,00

21.401.435,00

27.868.335,00

Short Term Payables

22.780.777,00

14.483.450,00

15.904.271,00

Cash Flow

5.511.519,00

6.917.985,00

11.964.064,00

Total Assets

33.053.505,00

27.477.136,00

34.895.602,00

Total Liabilities

23.757.707,00

15.223.605,00

18.848.832,00

Shareholders Funds

9.295.798,00

12.253.532,00

16.046.770,00

Personnel Costs

1.016.971,00

678.033,00

1.258.608,00

 


Ratios

 

 

 

31-12-2007

31-12-2008

31-12-2009

FINANCIAL SITUATION

 

 

 

General Liquidity

1,24

1,48

1,75

Immediate Liquidity

0,92

0,92

1,15

Financial Autonomy

0,28

0,45

0,46

Solvency

0,39

0,80

0,85

RENTABILITY

 

 

 

Sales Rentability

7,19 %

6,95 %

7,32 %

Sales Rate Increase

 

24,47 %

18,68 %

EFFICIÊNCY

 

 

 

Assets Turnover

1,03

1,54

1,44

 

 

Balance Sheet and Income Statement

 

Balance Sheet

CoinEURO                                                                                                Date31-12-2009

 

 

 

Gross Assets

Depreciations / Provisions

Net Assets

 

Intangible Assets

 

Subtotal

1.205.729,00

664.036,00

541.693,00

 

Tangible Assets

 

Subtotal

2.633.579,00

1.260.576,00

1.373.003,00

 

Financial Investments

 

Subtotal

5.112.571,00

 

5.112.571,00

 

Stocks

 

Subtotal

9.592.537,00

 

9.592.537,00

 

Short Term Receivable

 

Subtotal

15.220.766,00

141.911,00

15.078.855,00

 

Bank Deposits and Cash

 

Cash

9.584,00

 

9.584,00

Bank Deposites

3.135.982,00

 

3.135.982,00

Subtotal

3.145.566,00

 

3.145.566,00

 

Accruals and Deferrals

 

Deferred Cost

51.377,00

 

51.377,00

Subtotal

51.377,00

 

51.377,00

 

 

Total Assets

36.962.125,00

2.066.523,00

34.895.602,00

 


 

Shareholders Funds and Liabilities

Shareholders Funds

 

Capital

250.000,00

 

Treasury Stock:

 

 

Other Sup.

190.000,00

 

Reserves :

 

 

Free

561.710,00

 

Net Retained

11.367.797,00

 

Net Income For the Year

3.677.264,00

 

Total

16.046.770,00

 

 

Short Term Payable

 

Bank Loans

5.500.000,00

 

Supliers Fixed Asset

20.370,00

 

State and Other Public Bodies

239.371,00

 

Other Creditors

412.327,00

 

Trade Creditors

9.732.203,00

 

Subtotal

15.904.271,00

 

 

Medium and Long Term Payable

 

Bank Loans

2.591.654,00

 

Adv. For Clients

157.006,00

 

State and Other Public Bodies

98.465,00

 

Subtotal

2.847.125,00

 

 

Accruals and Deferrals

 

Accrued Charges

90.096,00

 

Diferred Income

7.340,00

 

Subtotal

97.436,00

 

 

TOTAL LIABILITIES

18.848.832,00

 

TOTAL LIABILITIES AND SHAREHOLDERS FUNDS

34.895.602,00

 

 

Income Statement

Costs and Losses

 

Cost of Materials Consumed and Goods Sold:

 

 

Subtotal

40.423.145,00

 

Outside Supplies and Services

4.847.512,00

 

Personnel Costs

 

 

Subtotal

1.258.608,00

 

Depreciation

425.318,00

 

Provisions

52.538,00

 

Subtotal

477.856,00

 

Other Operating Costs

96.732,00

 

Int. and Similar Costs:

 

 

Subtotal

1.042.301,00

 

Ext. Costs and Losses

482.259,00

 

Taxation Over Income

845.272,00

 

Net Income For the Year

3.677.264,00

 

 

Income and Profits

 

Sales of :

 

 

Products

49.972.556,00

 

Services Provided

272.958,00

 

Subtotal

50.245.514,00

 

Supplementary Income

8.903,00

 

Other Operating Income and Gains

1.399.029,00

 

Subtotal

1.407.932,00

 

Trading Securities Income

 

 

Int. and Similar Costs

 

 

Other

1.386.326,00

 

Extra Income and Gains

111.176,00

 

Net Income For the Year

3.677.264,00

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.20

UK Pound

1

Rs.73.17

Euro

1

Rs.61.88

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.